Cited by 19Drug Transport and Resistance MechanismsDrug Solubulity and Delivery SystemsPharmacogenetics and Drug Metabolism

No Evidence for the Involvement of the Multidrug Resistance-Associated Protein and/or the Monocarboxylic Acid Transporter in the Intestinal Transport of Fluvastatin in the Rat.

Lindahl, A, Frid, S, Ungell, AL, Lennernas, H·2000·AAPS PharmSci

Abstract

Fluvastatin, an amphiphilic anion, shows a nonlinear increase in effective intestinal permeability (P(eff)) with increasing lumenal concentrations in rats. The main objective of this study was to investigate whether or not this observation could be attributed to an efflux-mediated transport by the multidrug resistance-associated protein (MRP). In parallel, we investigated the possible involvement of the monocarboxylic acid transporter (MCT) in the rapid intestinal absorption of fluvastatin. Single-pass perfusions were performed in the ileum and colon of the rat, with and without the presence of well-established inhibitors/substrates for the MRP (probenecid) and the MCT (nicotinic acid). The results suggest that neither the MRP nor the MCT are involved to any significant extent in the absorption process of fluvastatin in the rat intestine. Thus, the previously reported concentration-dependent P(eff) of fluvastatin in these intestinal regions of the rat is probably not attributable to saturation of any efflux mediated by MRP.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1208/ps020326

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • FS uptake into cells is dependent on pH.

    “FS uptake into cells is dependent on pH.”
  • The low-dose growth-inhibitory action of FS at low pH can be understood by the previously demonstrated pH dependency of FS uptake across biological membranes.

    “The low-dose growth-inhibitory action of FS at low pH values can be understood in light of the previously demonstrated pH dependency of FS uptake across biological membranes [4].”
  • The uncharged protonated form of FS is taken up more readily than the charged molecule at serum pH.

    “The uncharged protonated form of FS in the acidic pH of the intestine is taken up more readily that the charged molecule is present at serum pH [4].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [9]9. in comparison with that of MDR1 and MRP. Cancer Lett. 1997;112:23-31.
  2. [17]17. Gotoh Y, Suzuki H, Kinoshita S, Hirohashi T, Kato Y, Sugiyama Y. Involvment of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats. J Pharmacol Exp Ther. 2000;292:433-439.

Cited by

Sorted by citations

Authors
Lindahl, A., Frid, S., Ungell, A., & Lennernas, H.
Affiliations
Uppsala University (SE)
Venue
AAPS PharmSci
Published
2000
Volume
02
Issue
03
Pages
e26
ISSN
1522-1059 (ISSN-L)
OpenAlex
W4205829098
Cited by
19
References
26
Citations by year
2024: 1 · 2023: 1 · 2014: 1 · 2013: 1 · 2012: 1
FWCI
0.29
Type
journal article
Language
en
Open access
closed
Locations
  • AAPS PharmSci (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
fluvastatin, multidrug resistance-associated protein, monocarboxylate transporters, intestinal absorption, intestinal permeability, efflux transport, probenecid, nicotinic acid, single-pass perfusion, rat intestine, statins
MeSH terms
Fluvastatin, Multidrug Resistance-Associated Protein 2, Acyl Coenzyme A, Animals, Colon, Enzyme Inhibitors, Fatty Acids, Monounsaturated, Ileum, Indoles, Intestinal Absorption, Intestinal Mucosa, Male, Niacin, Probenecid, Rats, Sprague-Dawley, Membrane Transport Proteins, ATP-Binding Cassette, Sub-Family C Proteins, Monocarboxylic Acid Transporters, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review